Atherogenic lipids profile relates to postprandial hyperglycemia and hyperinsulinemia due to whole body insulin resistance in prediabetic subjects

Yoshinori Miyazaki, Makoto Furugen, Hiroshi Akasaka, Shigeyuki Saitoh, Tetsuji Miura

Diabetes Division, Department of Internal Medicine, Muroran City General Hospital, Muroran, Japan.
Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.

DOI: 10.4236/jdm.2012.23044                

Abstract

Backgrounds: Differences in serum lipids profiles in different type of glucose intolerance are unclear. Aims: To characterize lipid profiles in different type of glucose intolerance, and to assess relationships between serum lipids profile and disturbance of glucose metabolism in prediabetic subjects. Methods: Using the measurements in medical check-up with 75 goral glucose tolerance test (OGTT), total of 620 male subjects, who are not on medications for metabolic diseases or hypertension, were divided into normal fasting glucose and glucose tolerance (NFG/ NGT), isolated impaired fasting glucose (iIFG), isolated impaired glucose tolerance (iIGT) and combined IFG and IGT (IFG/IGT) based on results of the OGTT. Results: Age and body mass index (BMI) were similar in the four groups. Matsuda index (an index of whole body insulin sensitivity) was lower in iIFG, iIGT and IFG/IGT as compared with NFG/NGT. Plasma insulin excursion during the OGTT was significantly higher in IFG/IGT versus NFG/NGT. Serum triglyceride level (TG) and TG to HDL ratio (TG/HDL) were higher in IFG/IGT versus NFG/NGT. Matsuda index was positively correlated with HDL and was inversely correlated with TG, LDL, non-HDL, TG/ HDL and LDL to HDL ratio (LDL/HDL). Backward stepwise multiple regression analysis indicated that increases in BMI, plasma insulin level at 60 min (PI₆₀) and plasma glucose level at 120 min in the OGTT were independently associated with increases in TG and TG/HDL. Increases in BMI and PI₆₀ were related to an increase in non-HDL and LDL/HDL and a decrease in HDL. Conclusions: These results indicate that postprandial hyperglycemia and hyperinsulinemia based on advanced insulin resistance are closely related to lipid risk factors of atherosclerotic macrovascular disease in prediabetic subjects.

Keywords

Atherosclerotic Lipids Profile; Impaired Fasting Glucose; Impaired Glucose Tolerance; Whole Body Insulin Resistance

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Haffner, S.M., Lehto, S., Ronnemaa, T., Pyorala, K. and Laakso, M. (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. The New England Journal of Medicine, 339, 229-234. doi:10.1056/NEJM199807233390404
[2]	Garg, A. and Grundy, S.M. (1990) Management of dyslipidemia in NIDDM. Diabetes Care, 16, 434-444.
[3]	American Diabetes Association (2003) Management of dyslipidemia in adults with diabetes (Position Statement). Diabetes Care, 26, S83-S86. doi:10.2337/diacare.26.2007.S83
[4]	Shaw, J.T., Purdie, D.M., Neil, H.A., Levy, J.C. and Turner, R.C. (1999) The relative risks of hyperglycemia, obesity and dyslipidemia in the relatives of patients of type II diabetes mellitus. Diabetologia, 42, 24-27. doi:10.1007/s001250051107
[5]	Haffner, S.M., Stern, M.P., Hazuda, H.P., Mitchell, B.D. and Patterson, J.K. (1990) Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? The Journal of the American Medical Association, 263, 2893-2898. doi:10.1001/jama.1990.03440210043030
[6]	Colagiuri, S. (2011) Epidemiology of Prediabetes. Medical Clinics of North America, 95, 299-307.
[7]	Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20, 1183-1197.
[8]	Genuth, S., Alberti, K.G., Bennett, P., Buse, J., Defronzo, R., Kahn, R., Kitzmiller, J., Knowler, W.C., Lebovitz, H., Lernmark, A., Nathan, D., Palmer, J., Rizza, R., Saudek, C., Shaw, J., Steffes, M., Stern, M., Tuomilehto, J. and Zimmet, P. (2003) The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 26, 3160-3167. doi:10.2337/diacare.26.11.3160
[9]	The DECODE Study Group, the European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Archives of Internal Medicine, 161, 397-404. doi:10.1001/archinte.161.3.397
[10]	The DECODE Study Group, on behalf of the European Diabetes Epidemiology Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and no cardiovascular diseases? Diabetes Care, 26, 688-696. doi:10.2337/diacare.26.3.688
[11]	Liu, J., Sempos, C., Donahue, R.P., Dorn, J., Trevisan, M. and Grundy, S.M. (2005) Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care, 28, 1916-1921. doi:10.2337/diacare.28.8.1916
[12]	Pischon, T., Girman, C.J., Sacks, F.M., Rifai, N., Stampfer, M.J. and Rimm, E.B. (2005) Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation, 112, 3375-3383. doi:10.1161/CIRCULATIONAHA.104.532499
[13]	Brunzell, J.D., Davidson, M., Furberg, C.D., Goldberg, R.B., Howard, B.V., Stein, J.H. and Witztum, J.L. (2008) Lipoprotein management in patients with cardiometabolic risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care, 31, 811-822. doi:10.2337/dc08-9018
[14]	Grundy, S.M., Cleeman, J.I., Merz, C.N., Brewer, H.B.Jr, Clark, L.T., Hunninghake, D.B., Pasternak, R.C., Smith, S.C.Jr. and Stone, N.J. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 110, 227-239. doi:10.1161/01.CIR.0000133317.49796.0E
[15]	Barzi, F., Patel, A., Woodward, M., Lawes, C.M., Ohkubo, T., Gu, D., Lam, T.H. and Ueshima, H. (2005) Asia Pacific Cohort Studies Collaboration. A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region. Annals of Epidemiology, 15, 405-413. doi:10.1016/j.annepidem.2005.01.005
[16]	Gaziano, J.M., Hennekens, C.H., O’Donnell, C.J., Breslow, J.L. and Buring, J.E. (1997) Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation, 96, 2520-2525. doi:10.1161/01.CIR.96.8.2520
[17]	Ingelsson, E., Schaefer, E.J., Contois, J.H., McNamara, J.R., Sullivan, L., Keyes, M.J., Pencina, M.J., Schoonmaker, C., Wilson, P.W., D’Agostino, R.B. and Vasan, R.S. (2007) Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. The Journal of the American Medical Association, 298, 776-785. doi:10.1001/jama.298.7.776
[18]	Kimura, T., Itoh, T., Fusazaki, T., Matsui, H., Sugawara, S., Ogino, Y., Endo, H., Kobayashi, K. and Nakamura, M. (2010) Low-density lipoprotein-cholesterol/high-density lipoprotein-cholesterol ratio predicts lipid-rich coronary plaque in patients with coronary artery disease—Integrated Backscatter Intravascular Ultrasound Study. Circulation Journal, 74, 1392-1398. doi:10.1253/circj.CJ-09-0849
[19]	Tanaka, S., Hayase, A., Hashimoto, A., Takagi, Y., Kondo, S., Hayashi, K., Yamamoto, M. and Iimura, O. (1990) Hypertension and cardiovascular diseases in an epidemiological study in Hokkaido, Japan. Journal of Cardiovascular Pharmacology, 16, S83-S86.
[20]	Matsuda, M. and DeFronzo, R.A. (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic glucose clamp. Diabetes Care, 22, 1462-1470. doi:10.2337/diacare.22.9.1462
[21]	Boizel, R., Benhamou, P.Y., Lardy, B., Laporte, F., Foulon, T. and Halimi, S. (2000) Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care, 23, 1679-1685. doi:10.2337/diacare.23.11.1679
[22]	Schwartz, S.L. (2006) Diabetes and dyslipidemia. Diabetes, Obesity and Metabolism, 8, 355-364.
[23]	Ginsberg, H.N. (2000) Insulin resistance and cardiovascular disease. Journal of Clinical Investigation, 106, 453-458. doi:10.1172/JCI10762
[24]	Kahn, B.B. and Flier, J.S. (2000) Obesity and insulin resistance. Journal of Clinical Investigation, 106, 473-481. doi:10.1172/JCI10842
[25]	Taskinen, M.-R. (1995) Insulin resistance and lipoprotein metabolism. Current Opinion in Lipidology, 6, 153-160. doi:10.1097/00041433-199506000-00007
[26]	Garvey, W.T., Kwon, S.D., Shaughnessy, S., Wallace, P., Hutto, A., Pugh, K., Jenkins, A.J., Klein, R.L. and Liao, Y. (2003) Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes, 52, 453-462. doi:10.2337/diabetes.52.2.453